Administration of 8-methoxypsoralen followed by ultraviolet A irradiation (PUV A treatment) has been used as a therapy fo r urticaria pigmentosa. The effect of PUVA treatment on cutaneous mast cells in mice was investigated by using giant granules of mast cells from C57BL/6-bgl jbgl (Chediak-Hi-gashi syndrome) mice as a marker. C57BL/ 6-+ j+ mice were lethally irradiated and rescued by bone marrow transplantation from C57BL/6-bgl jbgl mice. In the radiation chimeras, mast cells in the skin were of+ j+ type and mast-cell precursors migrating in the bloodstream were bgl jbgl. When PUV A treatment was applied to the skin of the radia-M ast cells are normal inhabitants of the skin, bur precursors of mast cells are derived from the bone marrow [1] . Although most of the progeny of hematopoietic stem cells leave the bone marrow only after maturation, undifferentiated precursors of mast cells leave the bone marrow, migrate via the bloodstream [2] [3] [4] , and invade the skin. After the invasion, they proliferate and differentiate into mast cells [5, 6] . Even after their morphologic differentiation, an appreciable proportion of mast cells retain a considerable proliferative potential [7] . When production of mast cells is required in the skin, differentiated mast cells localized in the skin proliferate first, and then bone marrow-derived precursors invade and differentiate into mast cells [8] .
Administration of 8-methoxypsoralen followed by ultraviolet A irradiation (PUV A treatment) has been used as a therapy fo r urticaria pigmentosa. The effect of PUVA treatment on cutaneous mast cells in mice was investigated by using giant granules of mast cells from C57BL/6-bgl jbgl (Chediak-Higashi syndrome) mice as a marker. C57BL/ 6-+ j+ mice were lethally irradiated and rescued by bone marrow transplantation from C57BL/6-bgl jbgl mice. In the radiation chimeras, mast cells in the skin were of+ j+ type and mast-cell precursors migrating in the bloodstream were bgl jbgl. When PUV A treatment was applied to the skin of the radia-M ast cells are normal inhabitants of the skin, bur precursors of mast cells are derived from the bone marrow [1] . Although most of the progeny of hematopoietic stem cells leave the bone marrow only after maturation, undifferentiated precursors of mast cells leave the bone marrow, migrate via the bloodstream [2] [3] [4] , and invade the skin. After the invasion, they proliferate and differentiate into mast cells [5, 6] . Even after their morphologic differentiation, an appreciable proportion of mast cells retain a considerable proliferative potential [7] . When production of mast cells is required in the skin, differentiated mast cells localized in the skin proliferate first, and then bone marrow-derived precursors invade and differentiate into mast cells [8] .
Abnormal increase of the mast cells characterizes several dermaroses, s uch as urticaria pigmentosa and systemic mastocytosis. Mast cells release various chemical mediators, including vasoactive amines , eosinophil chemotactic factors, and proteolytic enzymes Manuscript received November 1, 1989 ; accepted for publication on March 22, 1990 .
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DMBA: 7,12-dimethylbenz( a )anthrace ne tion chimeras, the total number of mast cells continued to decrease until the third week after the treatment and then recovered to pre-treatment levels. The initial reduction was attributed to the decrease of +/+-type mast cells, and the subsequent recovery to be as a result of the increase of bgl j bgl-type mast cells. This observation may explain the fact that the therapeutic effect ofPUVA treatment is transient. Symptoms of urticaria pigmentosa become manifest after the cessation of PUV A treatment probably because new mast cells differentiate from bone marrow-derived precursors. J Invest Dermato/95:353-358, 1990 [9] , and activated mas t cells produce some biologically active metabolites of arachidonic acids [10] and cytokines, including IL-3, IL-4, IL-5, IL-6, and GM-CSF [11-13]. These substances may directly or indirectly cause itching and wealing, disabling symptoms of these dermatoses [14] . Beside treatments ·with antihistamines [15 , 16] or adrenocortical steroids [17, 18] , the administration of 8-methoxypsoralen (8-MOP) followed by ultraviolet A (UV A) irradiation (PUV A treatment) has been reported to be effective in these dermatoses [19] [20] [21] [22] . Moreover, irradiation of ultraviolet B (UVB) is also reported to suppress mast cell-mediated wealing [23] .
Either PUV A treatment or UVB irradiation inhibits degranulation of mast cells elicited by various chemicals such as compound 48/80 and Concanavalin A [24] [25] [26] . On the other hand, Briffa eta] [20] , Kolde et al [27] , and Danno et al [26] reported that the number of mast cells did not change after PUV A treatment and UVB irradiation. Even if the total number of mast cells does not change, there is a possibility that the turnover of mast cells may be induced by the above-mentioned treatments. The mast cells that were located in the skin tissue before the treatments may be destroyed, and the decrease may be compensated by invasion and differentiation of bone marrow-derived precursors [28, 29] . To distinguish mast cells localized in the skin from those newly derived from the bone marrow precursors, we used giant granules of mast cells from beige (C57BL/6 -bgl jbgl, Chediak-Higashi sy ndrome) mice as a marker [8 ,30,31] . The C57BL/6-+/+ mice, which had received lethal irradiation and injection of bone marrow cells from C57BL/6-bgl / bgl donors, were used as recipients of PUV A treatment and UVB irradiation. Although the decrease in the total number of mast cells was moderate after these treatments, bgl j bgl-ty pe mas t cells increased remarkably.
MATERIALS AND METHODS

Radiation Chimeras
Mice of C57BL/6-(bgl/bgl and + / +) were raised in our labolatory and used at 8 weeks o( age. CSYBL/6-+/+ mice were irradiated (8 .5 Gy) using a Tosh iba x-ray mac hine Irradiation of Ultraviolet (UV) A UV machine for dermatology (Toshiba-Eisai M-DMR-1) was used. For UVB irradiation, five FL-20-SE-30 fluorescent lamps, which emitted UV of 280 to 3 70 nm (main emission, 295 to 315 nm; peak emission, 305 nm) were used . The power output was 2.0 mW /cm 2 at the target distance of 40 em; the value was measured with a UV radiometer (Tokyokogaku, Tokyo). For UVA irradiation, ten FL-20-BLB fluorescent black light lamps, which emitted UV of 300 to 357 nm (main emission, 347 to 357 nm; peak emission, 352 nm), were used. The power output was 7.0 mW jcm 2 at the target distance of 15 em. Before UV irradiation, the hair was cut with hair clippers, and the mice were anesthetized with Nembutal during the irradiation.
PUVA Treatment The original solution of 8-MOP (Taisho Pharmaceutical Co., Tokyo) was diluted with ethanol to 0.3% (final concentration, 3 mg/ml). Hairs of the dorsal skin were cut with hair clippers, and 0.5 ml of the diluted solution was applied with a blush. Mice were kept in a dark room for 1 h; their backs were then irradiated with UVA.
Mast Cell Counts The mice were killed by overinhalation of ether. Pieces of dorsal and ventral skin were removed and fixed in 10% formalin. Samples were embedded in paraffin and two serial sections (3 ;.1.1n thick) were cut from each sample. One section was stained with hematoxylin and eosin for histologic observation, the 3 ) , and incubated in Hank's solution containing collagenase (Type 1, 1.5 mg/ml, Sigma Chemical Co., St. Louis MO), hyaluronidase (Type 1-s, 1.5 mg/ml, Sigma), and 20o/o fetal bovine serum (HyClone, Logan UT) at 3rC for 2.5 h with gentle agitation. After the incubation, the cell suspensions were passed through a nylon mesh and washed with a-medium (GIBCO, Grand Island, NY) 3 times. The number of cells was counted with a standard hemocytometer. Dispersed skin cells (10 5 ) were cultured in the methylcdlulose medium; the composition of the medium and culture conditions have been described by Kanakura eta! [33] . As a source of growth factors, pokeweed mitogenstimulated spleen cell-conditioned medium (PWM-SCM) was used . PWM-SCM was prepared according to the method described by Nakahara and Ogawa (34), and the content of IL-3 and IL-4 in PWM-SCM has been shown by Hamaguchi et al (35}. The numbers of mast cell colonies containing ~50 cells were counted 16 d after the initiation of the culture.
Staining of Cultured Cells Individual colonies were lifted from the methylcellulose medium by using a 5-,ul Eppendorf pipette under direct microscopic visualization and collected in Eppendorf microcentrifuge tubes containing 0.4 ml Eagle's medium. After being washed twice with the medium, the samples were immediately spun in a cytocentrifuge (Cytospin 2, Shandon Southern, Elliott, IL) at 600 rpm for 5 min. The slides were stained with MayGri.inwald-Giemsa solution. 
RESULT S
The backs of radi ation chimeras w ere irradiated with various doses of UVB . M acroscopica ll y, UVB irradiation with 250 or 500 mJ/ cmz res ulted in erythema of the skin, and irradi atio n w ith 750 m]fcm 2 induced ul cers. Th e mi ce were kill ed 3 w eeks after irradiation, and th e skin ti ssues w ere exa mined microscopically. Acanthosis of epidermis, infiltra tion of neutrophils and lymphocytes , and fib ros is were observed in the skin of mice irradiated with 750 mJ /cm 2 UVB . The total number of mast cells showed a rather moderate change. H oweve r, when mast cell s w ere classified into + f +_ and bgl j bgl types, the former decreased and the latter increased sigruficantl y (Table I) . Two se parate expenments we re done; altho ug h the decrease o f + /+-type mas t cells in 500 mJ/cm 2 -irradiated mice was significa nt onl y in exp eriment 2, the res ults of both experime nts were consistent (Tabl e I) . Since 750 mJ /cm 2 UVB irradia tion appeared to ca use a secondary effe ct th rough the developme nt of ulcers, w e hereafter used 500 mJ/cm 2 UVB irrad iati on.
Administration of8-M O P was followed by various doses ofU VA irradiation. As macroscopi c and mi croscopic alterati ons of th e skin observed after 8-MO P ad ministratio n and 3.5 J /cm 2 U VA were comparable to those observed after 7 50 mJ/cm 2 U VB irradi ati on, we selected 2. 5 J /c m 2 UVA irradi ation as a PUVA treatment. Altho ugh neith er administra tion of 8-MOP alone nor irrad iatio n of UV A alo ne induced significa nt change in the number of mas t cells, a combL na ti on of8-MO P and UVA resul ted in a significa nt decrease in the to tal number of mast cell s (Table II) . When the ty pes of mast cells we re classifi ed ,+ / +-type mas t cell s decreased and bgl f bgl-type mas t cells increased remarkabl y (Fig 1, T able II) . Two separate experime nts w ere done, and th e results of both experiments were consis tent.
Another experiment was done to foll ow the sequential change in nu mbers of mast cells. Mice w ere kill ed at various times after either 500 mJ /cm 2 UVB irradiation or PUVA trea tme nt (UVA 2.5 J / cm 2 ). As all mice received one of these treatments to the dorsal skin, the nu mbers of mas t cell s in the ve ntral skin were used as a control. For this purpose, sa mples were harv ested from both the dorsal and ve ntral skin . In the dorsal ski n that rece ived either UVB irradiatio n or PUV A trea tment, the total number of mast cell s continued to decrease until th e third week after irradi ati on and then recovered to pre-irradiation levels. The initial reduction was attributed to the decrease of+ / +-type mast cell s, and the subsequent recovery was Weeks after UVB Irradiation Figure 2 . T he seq uencia! change in the numbers of skin mast cells after UVB irrad iation. A, dorsa l ski n; B, ventral ski n; opw sq uare, to tal mas t cells; ope11 circle, + j+-rype mast cell ; closed circle, bgljbgl-typc mas t cell . A resul t of single ex periment; each point represe nts mea n ± SE of five to eight mi ce. In tota l, 31mice were used.
• p <0.05; •• p < 0.01 , when compared ro th e va lue of nontrcated conrrol mice by Stud ent t test.
considered to be a res ult of th e increase of bgl j bgl-ty pe mas t cells (Figs 2 and 3) . Although a statisticall y significa nt increase of bgl / bgl-ty pe mast cells was observed in the ventral. skin 4 and 5 weeks after PUV A. treatment (Fig 3) , the bw logtc stgmfica nce was not clear. Types of mast cell colony-forming cells were inves ti ga ted 4 weeks after U VB irradi ation or PUVA trea tment. Skm-cell suspensions we re prepared fr.o m the dorsa l skin and plated in meth ylcellulose. Eac h mas t-cell colony co nsis ted of eith er + / +-type m as t cells alone or bgl j bgl-type mas t cells alone (Fig. 4 ) . Mas t cells of+ / + type were predominant in the skin cel l suspensiOns, but mas t cell colo nies of bgl f bgl type were predominant in methylcellul ose cultures (Table III) . DISCUSSIO N T he resul ts of the present study show ed that the number of mas t cells in the skin of mice decreased after U VB irrad iati on and PU VA treatment. As compared to U VB, PUVA seemed to be more potent in th e ability to decrease mas t cell s w ithout el iciting inflammation.
Granerus et al (21 J reported that amelioration of symp tom s such as itchin g and wea ling in patients w ith urtica ria pigmentosa was observed w ithin 2 w eeks after starting PUV A, and the patients were symptoml ess after 3-6 wee ks. Such amelioration of the clinical sym pto ms after th e ph ototh era py is considered to be re lated to t he decrease in n umber o f skin mas t cells. O n the other hand , sequential exa minati ons of th e skin of radi ation ch imeras revealed that the nu mber of mast cells returned to the pre-treatment level w ithin 4 weeks . T his observati on is co nsistent w ith the fact that the clinical effects of phototherapy are transient and symptoms become manifest after the cessation of the therapy (20) . In the prese nt study, we differentiated mast cells that were localized in the skin ti ssue from mast cells that were newly derived from the bone marrow by using giant granul es of mast cells from beige mice. Beca use we identified mast cells by staining with toluidine blu e, the possibility that the initial decrease of mast cells is due to the loss of stainability of the granules cannot be excluded . However, bgJ/bgl-type but not +/+-type mast cell s increased after the initial dec rease, and we consider that the decrease represents the loss of skin-localized mast cells induced by UVB irradiation or by PUV A trea tment, and that the recovery is attributed to the invasion and differentiation of bone marrow-derived precursors. This is consistent w ith the result of Sonoda et al [8) , who describ ed a comparable enough to induce a significant decrease of skin localized mast cell Therefore, UVB irrad iation and PUV A trea tment are more suitable than DMBA administratio n as an experimental procedure to induct the turnover of mast cells. When skin cells of radiation chimeras that had received UVB irradiation or PUV A treatment were cultured in methylcellulose, m.ast cel l co lo nies of both+/+ and bgJjbgJ types developed (Tablt III) . This indicates that mast cell colony-forming cells of + /+ ori· gin su rvived after these treatments, and sugges ted that mast c~l damage induced by these treatments may be compensated by prohleration of mast cell precursors existing in the skin in addition supply from the bone marrow. H owever, w hen the proportion ' morphologically identifi able+ /+-type mast cells was compared th at of +/+-type mast cell colony-forming cells in the skin which received UVB irradiatio n or PUV A treatment, the former was significantl y larger than the latter (Table lll) . Although the morphology of mast cel l colony-forming cells localized in the skin has n been determined, Kanakura et al (33] suggested that some morphologically identifiable skin mast cells th emselves may form mast c colonies in methylcellulose. In fact, about 30% of morphologically identifiable mast cell s in the peritoneal cavity produce mast cefi colonies [34] . Some explanatio ns are possibl e for the results show in Table lll . Skin mast cells w ith colony-forming potential may~ more sensitive to UVB irradiation or PUV A treatment than skin mast cells without colony-forming potential. Thus, after UVB im-. diation or PUV A trea tment,+ / +-type cells were remarkable wh the skin cells were investigated morphologically, but bgJ jbgl-typ.. • colonies were apparentl y predominant w hen the skin cells w ert • Skin cel l suspensions of six radiation chimeras were pooled and plated in methylccllulose; 500 mast cell s and 155 mast-cell colonies were classified.
• Skin cell suspensions of six radiation chimeras were pooled and plated in methylccllulose; 400 mast cells and 207 mast-cell colonies were classified.
' The proportion of + / +-type (or bgl jbs_l-type) mast ce lls were significantly different from the popu lation of +/+-type (or bglj bgl-type) mast cell colony-forming cells after either UVB irradiation or PUVA treatment (p < 0.01, when compared by X 2 test).
cultu red in methylcellulose . Some + / +-type mast cell s with colony-fo rming potential, which survived the UVB irradiation or the PUV A treatment, m ay lose colony-forming potential after divisions induced by loss of neighboring m as t cell s. 
